Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The global market for acromegaly treatment reached a value of about USD 1.50 billion in 2021. The market is further expected to grow at a CAGR of about 7.6% in the forecast period of 2022-2027 to reach a value of around USD 2.33 billion by 2027.
North America, owing to the high demand for novel prescriptions, innovative products, and the presence of established players in the market, is expected to be the leading region for acromegaly treatment. The United States and Canada are the largest markets for acromegaly treatment; due to the growing population prevalence of the disease, the medical institutes are spreading awareness of treatments with the government introducing favourable policies. Furthermore, the rise in collaborations and effort in research and development by the established organisations to develop new products and innovative procedures are propelling the demand for treatment, which in turn, helps in market growth.
Asia Pacific is showing promising growth opportunities for the market. The region is going through industrialisation, and people are increasingly moving to urban areas seeking a better lifestyle, which shows the rising awareness among people. The government is increasing their healthcare expenditure to establish an improved infrastructure, and with development in various sectors, the spending power of people will simultaneously increase, which will further drive the market growth.
Acromegaly is a hormonal disorder that develops in the pituitary gland, which increases growth hormone production. A non-cancerous tumour usually causes it. In acromegaly treatment, the goal is to restore the pituitary gland to function normally and produce normal levels of growth hormone.
By product, the market for acromegaly treatment includes:
The end-uses of the acromegaly treatment include:
The regional markets for acromegaly treatment can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa, with North America leading the market and Asia Pacific being the fastest-growing region.
As the population rises, the number of patients is increasing, and to provide safe and sufficient services, and the healthcare infrastructure is being developed continuously. Advancements in surgery and innovative alternate techniques are further broadening the market limits. The high cost of surgery can pose a little setback to market growth. However, governments are introducing favourable policies to spread medical treatment awareness. Multiple medical institutes and organisations are focusing on research and development to introduce novel medications, such as somatostatin analogs, which help stop the excess production of growth hormones. Additionally, with the launch of technologically advanced detection techniques like radiosurgery, radio imaging technologies provide cost-effective options for diagnosis with minimum side effects.
The report gives a detailed analysis of the following key players in the global acromegaly treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Product||
|Breakup by End Use||
|Breakup by Region||
|Report Price and Purchase Option||Explore our purchase options that are best suited to your resources and industry needs.|
|Delivery Format||Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
7 Industry Opportunities and Challenges
8 Global Acromegaly Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Acromegaly Treatment Historical Market (2017-2021)
8.3 Global Acromegaly Treatment Market Forecast (2022-2027)
8.4 Global Acromegaly Treatment Market by Product
8.4.1 Somatostatin Analogs (SSA)
22.214.171.124 Market Share
126.96.36.199 Historical Trend (2017-2021)
188.8.131.52 Forecast Trend (2022-2027)
8.4.2 Growth Hormone Receptor Antagonist (GHRA)
184.108.40.206 Market Share
220.127.116.11 Historical Trend (2017-2021)
18.104.22.168 Forecast Trend (2022-2027)
8.5 Global Acromegaly Treatment Market by End Use
22.214.171.124 Market Share
126.96.36.199 Historical Trend (2017-2021)
188.8.131.52 Forecast Trend (2022-2027)
184.108.40.206 Market Share
220.127.116.11 Historical Trend (2017-2021)
18.104.22.168 Forecast Trend (2022-2027)
8.6 Global Acromegaly Treatment Market by Region
8.6.1 Market Share
22.214.171.124 North America
126.96.36.199 Asia Pacific
188.8.131.52 Latin America
184.108.40.206 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
220.127.116.11 United States of America
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
18.104.22.168 United Kingdom
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
22.214.171.124 Saudi Arabia
126.96.36.199 United Arab Emirates
188.8.131.52 South Africa
10 Market Dynamics
10.1 SWOT Analysis
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Novartis AG
184.108.40.206 Company Overview
220.127.116.11 Product Portfolio
18.104.22.168 Demographic Reach and Achievements
11.2.2 Ipsen Biopharmaceuticals, Inc.
22.214.171.124 Company Overview
126.96.36.199 Product Portfolio
188.8.131.52 Demographic Reach and Achievements
11.2.3 Chiasma, Inc.
184.108.40.206 Company Overview
220.127.116.11 Product Portfolio
18.104.22.168 Demographic Reach and Achievements
11.2.4 Pfizer Inc.
22.214.171.124 Company Overview
126.96.36.199 Product Portfolio
188.8.131.52 Demographic Reach and Achievements
11.2.5 Ionis Pharmaceuticals, Inc.
184.108.40.206 Company Overview
220.127.116.11 Product Portfolio
18.104.22.168 Demographic Reach and Achievements
12 Industry Events and Developments
List of Key Figures and Tables
1. Global Acromegaly Treatment Market: Key Industry Highlights, 2017 and 2027
2. Global Acromegaly Treatment Historical Market: Breakup by Product (USD Billion), 2017-2021
3. Global Acromegaly Treatment Market Forecast: Breakup by Product (USD Billion), 2022-2027
4. Global Acromegaly Treatment Historical Market: Breakup by End Use (USD Billion), 2017-2021
5. Global Acromegaly Treatment Market Forecast: Breakup by End Use (USD Billion), 2022-2027
6. Global Acromegaly Treatment Historical Market: Breakup by Region (USD Billion), 2017-2021
7. Global Acromegaly Treatment Market Forecast: Breakup by Region (USD Billion), 2022-2027
8. North America Acromegaly Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
9. North America Acromegaly Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
10. Europe Acromegaly Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
11. Europe Acromegaly Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
12. Asia Pacific Acromegaly Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
13. Asia Pacific Acromegaly Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
14. Latin America Acromegaly Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
15. Latin America Acromegaly Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
16. Middle East and Africa Acromegaly Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
17. Middle East and Africa Acromegaly Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
18. Global Acromegaly Treatment Market Structure
In 2021, the global market for acromegaly treatment attained a value of nearly USD 1.50 billion.
The market is projected to grow at a CAGR of 7.6% between 2022 and 2027.
The market is estimated to witness healthy growth in the forecast period of 2022-2027 to reach USD 2.33 billion by 2027.
The increasing prevalence of diseases among the growing population, technological advancements, and increasing investment in healthcare are the major industry drivers.
The players' key industry trends are technological advancements and favourable government policies to reduce treatment expenses.
The major regions in the industry are North America, Latin America, the Middle East, Africa, Europe, and the Asia Pacific, with North America being the leading region in the market and Asia Pacific growing at an exponential rate.
The different products in the market include somatostatin analogs (SSA) and growth hormone receptor antagonist (GHRA), among others.
The end-users for acromegaly treatment in the market include Hospitals and Clinics, among others.
The major players in the industry are Novartis AG, Ipsen Biopharmaceuticals, Inc., Chiasma, Inc., Pfizer Inc., and Ionis Pharmaceuticals, Inc., among others.
The global acromegaly treatment market attained a value of USD 1.50 billion in 2021, driven by the rising prevalence of diseases among the growing population. Aided by the ever-increasing technological advancements and launch of novel medications, the market is expected to witness further growth in the forecast period of 2022-2027, growing at a CAGR of 7.6%. The market is projected to reach USD 2.33 billion by 2027.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its products, the market can be segmented into somatostatin analogs (SSA) and growth hormone receptor antagonist (GHRA), among others. The treatment finds end-uses in hospitals and clinics, among others. The major regional markets for xx are North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, with North America establishing itself as the largest market region and Asia Pacific showing the most growth opportunities. The key players in the above market include Novartis AG, Ipsen Biopharmaceuticals, Inc., Chiasma, Inc., Pfizer Inc., and Ionis Pharmaceuticals, Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.